PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29188495-7	2018	Using targeted immunoblotting approach, we observed the presence of several known TBI biomarkers such as alphaII-spectrin breakdown products (BDPs), GFAP, and its BDPs and UCH-L1 in higher concentrations in MV/E from TBI CSF than their counterparts from control CSF.	tbi	82-85	glial fibrillary acidic protein	Homo sapiens	149-153	
22497529-5	2012	Glial fibrillary acidic protein (GFAP), a brain-specific biomarker that is released into the blood following TBI and stroke, is being explored for potential diagnostic and prognostic value in these indications.	tbi	109-112	glial fibrillary acidic protein	Homo sapiens	0-31	
22497529-5	2012	Glial fibrillary acidic protein (GFAP), a brain-specific biomarker that is released into the blood following TBI and stroke, is being explored for potential diagnostic and prognostic value in these indications.	tbi	109-112	glial fibrillary acidic protein	Homo sapiens	33-37	
22497529-11	2012	Additional clinical studies will also be required to define the temporal patterns of GFAP release in IS, ICH, SAH, and TBI, and their potential use in the differential diagnosis of these conditions.	tbi	119-122	glial fibrillary acidic protein	Homo sapiens	85-89	
22497529-12	2012	Finally, such research could demonstrate the ability of GFAP test results to provide unique clinical information that informs management decisions for TBI and stroke patients.	tbi	151-154	glial fibrillary acidic protein	Homo sapiens	56-60